November 03, 2025

Metastatic ER-Positive, HER2-Negative Breast Cancer: Novel Treatment Combination Improves Progression-Free Survival

Patients with ER-positive, HER2-negative advanced breast cancer showed significantly improved progression-free survival (PFS) when treated with an oral combination regimen that includes giredestrant, ...

The ASCO Post

October 31, 2025

A Young Hematologist’s Take on ICML 2025

The ASCO Post

October 31, 2025

Addition of Brentuximab Vedotin to Lenalidomide/Rituximab in Relapsed or Refractory DLBCL

The ASCO Post

November 10, 2025

Variation in PSA Levels in Annual Testing Among Individuals Without a Prostate Cancer Diagnosis

The ASCO Post

October 30, 2025

Overall Survival After Hormonal Therapy vs Hysterectomy in Early Endometrial Cancer

The ASCO Post

October 30, 2025

Digital Histopathology and Automated Classification of Pediatric Sarcomas

The ASCO Post

The Myelofibrosis Journey From Diagnosis to Long-Term Management

This new program delivers concise, expert-informed education to guide decision-making across all stages of myelofibrosis (MF) care.

Explore the Resource

Latest Headlines

January 23, 2026

Helping Patients Weigh Medical Advice from Friends and Family

Keck Medicine of USC

January 22, 2026

Pembrolizumab Plus Weekly Paclitaxel Improves Survival Outcomes in Platinum-Resistant Recurrent Ovarian Cancer

The ASCO Post

January 22, 2026

Could Opportunistic Salpingectomy Prevent Ovarian Cancer in Postreproductive Women?

The ASCO Post

January 22, 2026

Investigating the Mechanisms of Cardiovascular Adverse Events Linked to Certain Cancer Treatments

The ASCO Post

January 21, 2026

Addition of Durvalumab to BCG After TURBT for BCG-Naive, High-Risk NMIBC

The ASCO Post

January 21, 2026

IMvigor011 Subgroup Analysis: Role of ctDNA in Guiding Adjuvant Treatment for Muscle-Invasive Bladder Cancer

The ASCO Post

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

Conference Coverage

All Conference News View Conference Calendar

ESMO Congress 2025

January 22, 2026

Pembrolizumab Plus Weekly Paclitaxel Improves Survival Outcomes in Platinum-Resistant Recurrent Ovarian Cancer

The ASCO Post

January 06, 2026

Validation of Pathology-AI Integration Tool for Risk Stratification in Locally Advanced Colon Cancer Without Chemotherapy

The ASCO Post

January 02, 2026

Benefits Mount for TROP2-Directed Antibody-Drug Conjugates in Triple-Negative Breast Cancer

The ASCO Post

SUO 2025

January 21, 2026

IMvigor011 Subgroup Analysis: Role of ctDNA in Guiding Adjuvant Treatment for Muscle-Invasive Bladder Cancer

The ASCO Post

January 21, 2026

KEYNOTE-905: Perioperative Immunotherapy Regimen Active in Cisplatin-Ineligible MIBC

The ASCO Post

January 06, 2026

Intravesical Cretostimogene Grenadenorepvec Shows Strong High-Grade Recurrence-Free Survival in BCG-Unresponsive Papillary-Only Non–Muscle-Invasive Bladder Cancer

The ASCO Post

Royal College of Psychiatrists (RCPsych) International Congress

January 15, 2026

How Treatment Is Given May Matter Most

Conexiant

Clinical Guidelines

January 22, 2026

Pembrolizumab Plus Weekly Paclitaxel Improves Survival Outcomes in Platinum-Resistant Recurrent Ovarian Cancer

The ASCO Post

January 22, 2026

Could Opportunistic Salpingectomy Prevent Ovarian Cancer in Postreproductive Women?

The ASCO Post

January 21, 2026

IMvigor011 Subgroup Analysis: Role of ctDNA in Guiding Adjuvant Treatment for Muscle-Invasive Bladder Cancer

The ASCO Post

January 21, 2026

KEYNOTE-905: Perioperative Immunotherapy Regimen Active in Cisplatin-Ineligible MIBC

The ASCO Post

Commentary & Perspectives

January 09, 2026

The Diagnosis I Couldn’t Deliver: An Oncologist’s Journey Between Roles

The ASCO Post

January 09, 2026

Narrative Medicine: A Clinical Tool for the Oncology Advanced Practitioner

JADPRO

July 10, 2023

Expert Point of View: Pamela L. Kunz, MD and Corrie Marijnen, MD, PhD

The ASCO Post

January 25, 2023

Communicating Prognosis: A Core Competency of Patient-Centered Oncology Care

The ASCO Post

FDA & Government News

August 29, 2023

FDA Approves Luspatercept-aamt as First-Line Treatment for Adult Patients With Lower-Risk MDS and Anemia Who May Require Transfusions

The ASCO Post

January 25, 2021

FDA Approves First Oral Hormone Therapy for Treating Advanced Prostate Cancer

The ASCO Post

February 21, 2024

FDA Approves Biweekly Teclistamab Dosing Regimen for Patients With Multiple Myeloma

The ASCO Post

June 21, 2023

FDA Launches Pilot Program to Help Reduce Risks Associated With Using Laboratory Developed Tests to Identify Cancer Biomarkers

The ASCO Post

Business Management

June 10, 2024

How the Museum of Medicine and Biomedical Discovery Aims to Bring Scientific Achievements of the Past, Present, and Future to Life

The ASCO Post

April 10, 2025

American Cancer Society Launches CEO Search

The ASCO Post

January 29, 2025

Clinical Posters From JADPRO Live 2024

JADPRO

November 05, 2025

How a $2 Billion Gift to the Knight Cancer Institute May Accelerate Cancer Advances and Streamline Care for Patients

The ASCO Post

Trending Now

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dental Technology

Inside Dentistry

The ASCO Post

JADPRO

JNCCN

JNCCN 360

Corneal Physician

Glaucoma Physician

New Retinal Physician

Ophthalmology Management

Ophthalmic Professional

Presbyopia Physician

Retinal Physician

The Ophthalmologist

Contact Lens Spectrum

Eyecare Business

Optometric Management

Presbyopia Physician

The New Optometrist

The Pathologist

Variation in PSA Levels in Annual Testing Among Individuals Without a Prostate Cancer Diagnosis

Overall Survival After Hormonal Therapy vs Hysterectomy in Early Endometrial Cancer

Digital Histopathology and Automated Classification of Pediatric Sarcomas

Latest Headlines

Daily News

Recommendations

Trending Now

1

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Featured Videos

Conference Coverage

ESMO Congress 2025

SUO 2025

Royal College of Psychiatrists (RCPsych) International Congress

Clinical Guidelines

Commentary & Perspectives

FDA & Government News

Business Management